Evidence map›Paper›PMID 40566790›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2025

Associations between objective sleep metrics and brain structure in cognitively unimpaired adults: interactions with sex and Alzheimer's biomarkers.

Laura Stankeviciute, Núria Tort-Colet, Ana Fernández-Arcos, Gonzalo Sánchez-Benavides, Carolina Minguillón, Karine Fauria, Sebastian Camillo Holst, Pilar Garcés, Thomas Mueggler, Henrik Zetterberg and 7 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Laura StankeviciuteBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Núria Tort-ColetBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Ana Fernández-ArcosBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Gonzalo Sánchez-BenavidesBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Carolina MinguillónBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Karine FauriaBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Sebastian Camillo HolstRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Pilar GarcésRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Thomas MuegglerRoche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.
Kaj BlennowDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden.
Álex IranzoSleep Unit, Neurology Service, Hospital Clínic Barcelona, Universitat de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain.
Marc Suárez-CalvetBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Juan Domingo GispertBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
José Luis MolinuevoBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.
Oriol Grau-RiveraBarcelonaβeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain.ORCID 0000-0002-4730-5341
ALFA Study

Funding

The effects of iron on oxidative stress and Alzheimer's biomarkers in amyloid-positive and negative elderly normalR01AG068398 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHIANG, GLORIA CHIA-YI · 2020 to 2024
$2.8M
AD Strategic FundALF‑agreement ALFGBG‑715986Alzheimer Drug Discovery Foundation 201809-2016862Alzheimer Drug Discovery Foundation RDAPB‑201809‑2016615Alzheimer's Association ADSF-21-831376-CAlzheimer's Association ADSF-21-831377-CAlzheimer's Association ADSF-21-831381-CAlzheimer's Association 2021 Zenith ZEN‑21‑848495Alzheimer's Association Research Fellowship Program 2019-AARF-644568Bluefield ProjectCatalan Government 2017-SGR-892EIT Digital 2021EU/EFPIA Innovative Medicines Initiative Joint Undertaking AMYPAD 115952European Research CouncilEuropean Union Joint Program for Neurodegenerative Disorders JPND2019‑466‑236European Union Joint Programme - Neurodegenerative Disease Research JPND2021-00694European Union's Horizon 948677European Union's Horizon Europe 101053962EU's Horizon 2020Hjärnfonden FO2017‑0243Instituto de Salud Carlos III PI19/00117Instituto de Salud Carlos III PI22/00456'la Caixa' Foundation 100010434'la Caixa' Foundation LCF/PR/GN17/50300004Marie Skłodowska-Curie 847648Marie Skłodowska-Curie 860197Marie Skłodowska-Curie LCF/BQ/PR21/11840004Ministerio de Ciencia e Innovacion, Spanish Research Agency PID2020-119556RA-I00Ministerio de Ciencia y Universidades RTI2018‑102261Ministry of Business and KnowledgeNIA NIH HHS R01 AG068398NIH HHS 1R01AG068398‑01Olav Thon FoundationSpanish Ministry of Science and Innovation RYC‑2013‑13054Spanish Ministry of Science, Innovation and Universities IJC2020-043417-IStiftelsen för Gamla TjänarinnorSwedish Alzheimer Foundation AF‑742881Swedish government and the County CouncilsSwedish Research Council 2017‑00915Swedish State Support for Clinical Research ALFGBG-71320TriBEKa Imaging Platform project TriBEKa‑17‑519007UK Dementia Research Institute UKDRI-1003Universities and Research Secretariat
6 · The paper itself

Abstract

introductionSleep disturbances are prevalent in Alzheimer's disease (AD), probably emerging during its preclinical stage. Poor subjective sleep quality is linked to reduced brain volume and cortical thickness (CTh), but associations with objective sleep measures, particularly regarding sex and AD pathology, remain unclear.

methodsWe characterized 171 cognitively unimpaired adults from the ALzheimer and FAmilies (ALFA) Sleep study using actigraphy, MRI, amyloid beta 42/40, and phosphorylated tau at threonine 181 in cerebrospinal fluid.

resultsLower sleep efficiency, higher wake after sleep onset (WASO), and sleep fragmentation were associated with lower CTh in the medial temporal lobe and other regions linked with AD and sleep disruption, even after adjusting for AD biomarkers. Sex and AD biomarkers modified these associations, with longer WASO showing a stronger correlation with lower CTh in females. DISCUSSION: Disrupted sleep may reduce cortical integrity independently of AD biomarkers, suggesting alternative pathways. Females appear more vulnerable to impaired sleep, and AD pathology may exacerbate AD-related changes in CTh. HIGHLIGHTS: Poor sleep efficiency, increased WASO, and sleep fragmentation are associated with reduced CTh in regions vulnerable to early AD, independently of amyloid and tau pathology. In the presence of AD pathology, this relationship is altered, with A+T+ individuals exhibiting increased CTh associated with sleep disruption. Sex-specific effects suggest females are more vulnerable to sleep-related cortical thinning. These findings highlight the potential of targeting sleep as a secondary prevention strategy to preserve brain integrity and mitigate neurodegenerative processes in AD-vulnerable regions.

Indexed as

Alzheimer DiseaseBrainSleepSleep Wake DisordersActigraphyAgedAmyloid beta-PeptidesBiomarkersFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPeptide FragmentsSex Factorstau ProteinsAmyloid beta-PeptidesBiomarkersPeptide Fragmentstau Proteinsactigraphycortical thicknesspreclinical ADsex differencessleep

Identifiers

PMID40566790
PMCPMC12198473

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.